deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02186470

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer

Feasibility of Assessing Radiation Response With MRI/CT Directed Preoperative Accelerated Partial Breast Irradiation in the Prone Position for Hormone Responsive Early Stage Breast Cancer

Sponsor: Ohio State University Comprehensive Cancer Center

Conditions Estrogen Receptor-positive Breast Cancer Invasive Ductal Breast Carcinoma Invasive Ductal Breast Carcinoma With Predominant Intraductal Component Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate Mucinous Ductal Breast Carcinoma Papillary Ductal Breast Carcinoma Progesterone Receptor-positive Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Tubular Ductal Breast Carcinoma
Interventions accelerated partial breast irradiation image-guided radiation therapy intensity-modulated radiation therapy therapeutic conventional surgery
Updated 13 times since 2017 Last updated: Sep 16, 2025 Started: Apr 29, 2016 Primary completion: Sep 4, 2025 Completion: Sep 4, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Estrogen Receptor-positive Breast Cancer and Invasive Ductal Breast Carcinoma, this trial is completed. The trial is conducted by Ohio State University Comprehensive Cancer Center and has accumulated 13 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshot~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshot~Jan 2021 – ~May 2023 · 28 months · monthly snapshot~May 2023 – ~Jul 2024 · 14 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Jun 2025 · 3 months · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Oct 2025 · 3 months · monthly snapshot~Oct 2025 – present · 11 months · monthly snapshot

Change History

13 versions recorded

  1. Oct 2025 — Present [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  2. Jul 2025 — Oct 2025 [monthly]

    Active Not Recruiting NA

  3. Jun 2025 — Jul 2025 [monthly]

    Active Not Recruiting NA

  4. Mar 2025 — Jun 2025 [monthly]

    Active Not Recruiting NA

  5. Sep 2024 — Mar 2025 [monthly]

    Active Not Recruiting NA

▶ Show 8 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  2. May 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

    Status: Unknown Status → Active Not Recruiting

  3. Jan 2021 — May 2023 [monthly]

    Unknown Status NA

  4. Oct 2019 — Jan 2021 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  5. Jun 2018 — Oct 2019 [monthly]

    Recruiting NA

  6. Oct 2017 — Jun 2018 [monthly]

    Recruiting NA

  7. Feb 2017 — Oct 2017 [monthly]

    Recruiting NA

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ohio State University Comprehensive Cancer Center
Data source: Ohio State University Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations